Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles
暂无分享,去创建一个
Ameya R. Kirtane | G. Traverso | R. Langer | A. Hayward | Hyunjoon Kim | K. Ishida | Chaoyang Tang | N. U. Rajesh | N. Kim
[1] Shriya S. Srinivasan,et al. RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract , 2022, Sci. Robotics.
[2] R. Siegel,et al. An Artificial Gut/Absorption Simulator: Description, Modeling, and Validation Using Caffeine , 2022, The AAPS Journal.
[3] M. Ji,et al. Laparotomy-Induced Peripheral Inflammation Activates NR2B Receptors on the Brain Mast Cells and Results in Neuroinflammation in a Vagus Nerve-Dependent Manner , 2022, Frontiers in Cellular Neuroscience.
[4] Ameya R. Kirtane,et al. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections , 2022, Matter.
[5] Aaron M. Rosenfeld,et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses , 2021, Immunity.
[6] R. Haque,et al. Oral rotavirus vaccine shedding as a marker of mucosal immunity , 2021, Scientific Reports.
[7] G. Domańska,et al. Increased mortality and altered local immune response in secondary peritonitis after previous visceral operations in mice , 2021, Scientific Reports.
[8] A. Anselmo,et al. Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi , 2021, The AAPS Journal.
[9] I. Mellman,et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines , 2022, Nature Immunology.
[10] K. Nam,et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver , 2021, Science Advances.
[11] W. Jiskoot,et al. Addressing the Cold Reality of mRNA Vaccine Stability , 2020, Journal of Pharmaceutical Sciences.
[12] C. Duvall,et al. Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists , 2020, ACS central science.
[13] Ameya R. Kirtane,et al. Gastrointestinal synthetic epithelial linings , 2020, Science Translational Medicine.
[14] R. Langer,et al. Advances in oligonucleotide drug delivery , 2020, Nature Reviews Drug Discovery.
[15] J. Mascola,et al. SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness , 2020, Nature.
[16] Xia Zhong,et al. A Thermostable mRNA Vaccine against COVID-19 , 2020, Cell.
[17] J. Mascola,et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.
[18] D. Ferguson,et al. TLR7/8 Agonist Loaded Nanoparticles Augment NK Cell-mediated Antibody-based Cancer Immunotherapy. , 2020, Molecular pharmaceutics.
[19] Juan F Burgueño,et al. Epithelial Toll-like receptors and their role in gut homeostasis and disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[20] S. Gurunathan,et al. The promise of mRNA vaccines: a biotech and industrial perspective , 2020, npj Vaccines.
[21] A. Depicker,et al. Evaluating single-domain antibodies as carriers for targeted vaccine delivery to the small intestinal epithelium. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[22] Na Yoon Kim,et al. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition , 2019, Science Translational Medicine.
[23] R. Weiss,et al. Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] Robert Langer,et al. A luminal unfolding microneedle injector for oral delivery of macromolecules , 2019, Nature Medicine.
[25] M. Lu,et al. Engineering a Nanoscale Al‐MOF‐Armored Antigen Carried by a “Trojan Horse”‐Like Platform for Oral Vaccination to Induce Potent and Long‐Lasting Immunity , 2019, Advanced Functional Materials.
[26] D. Esterházy,et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses , 2019, Nature.
[27] Robert Langer,et al. An ingestible self-orienting system for oral delivery of macromolecules , 2019, Science.
[28] Ronnie H. Fang,et al. Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination. , 2019, Nano letters.
[29] N. Grassly,et al. Interventions to improve oral vaccine performance: a systematic review and meta-analysis , 2019, The Lancet. Infectious diseases.
[30] J. Kolls,et al. Faculty Opinions recommendation of B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[31] Fuping Zhang,et al. B Cells Are the Dominant Antigen‐Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus‐Derived Nanoparticle Antigen , 2018, Immunity.
[32] D. Ferguson,et al. Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. , 2018, Biomaterials.
[33] D. Weissman,et al. mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.
[34] N. Grassly,et al. Causes of impaired oral vaccine efficacy in developing countries , 2017, Future microbiology.
[35] C. Jewell,et al. A poly(beta-amino ester) activates macrophages independent of NF-κB signaling. , 2017, Acta biomaterialia.
[36] Kimberly J. Hassett,et al. Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[37] James I. Andorko,et al. Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters). , 2017, Journal of biomedical materials research. Part A.
[38] D. Accoto,et al. A Swallowable Smart Pill for Local Drug Delivery , 2016, Journal of Microelectromechanical Systems.
[39] M. Coimbra,et al. Structure-function relationships of immunostimulatory polysaccharides: A review. , 2015, Carbohydrate polymers.
[40] N. Fierer,et al. The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome , 2015, PloS one.
[41] L. McAllister,et al. Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial , 2014, The Lancet.
[42] C. Herzog. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature , 2014, Expert review of vaccines.
[43] G. Vanham,et al. Challenges and advances towards the rational design of mRNA vaccines. , 2013, Trends in molecular medicine.
[44] C. Ballantyne,et al. CD11a Regulates Effector CD8 T Cell Differentiation and Central Memory Development in Response to Infection with Listeria monocytogenes , 2013, Infection and Immunity.
[45] Zhaolin Hua,et al. TLR signaling in B-cell development and activation , 2012, Cellular and Molecular Immunology.
[46] Nathaniel S Wang,et al. Molecular programming of B cell memory , 2011, Nature Reviews Immunology.
[47] Y. Schneider,et al. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] N. Van Rooijen,et al. Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues , 2008, Science.
[49] Gideon Kersten,et al. Needle-free vaccine delivery , 2007, Expert opinion on drug delivery.
[50] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[51] F. Sallusto,et al. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells , 2000, Nature Immunology.
[52] Lei Zhang,et al. Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines. , 2016, Biomaterials.
[53] R. Mumper,et al. In Vitro and In Vivo Evaluation of a Water-in-Oil Microemulsion System for Enhanced Peptide Intestinal Delivery , 2012, The AAPS Journal.
[54] A. Stammati,et al. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.
[55] Myron M. Levine,et al. Can needle-free administration of vaccines become the norm in global immunization? , 2003, Nature Medicine.
[56] I. Wilding,et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. , 2002, International journal of pharmaceutics.